
Blavatnik Startups
Startups
To date the Blavatnik Fund has launched 28 startups. The below list highlights the currently active ventures and ventures that have been acquired. Those that are either raising a round or seeking leadership are denoted with a *.

Fundraising status: Raised Series A (2022)
Clinical Stage: Preclinical
CEO: Mark Cockett
Faculty Founder: Ranjit Bindra

Fundraising status: Angel Funding
Stage: Commercial, engaging FDA for clinical indication
CEO: Tim Kish
Faculty Founder: Bruce Wexler

Fundraising status: SBIR (Awarded 2023)
Stage: Preclinical
CEO: Seeking CEO
Faculty Founder: Choukri Ben Mamoun

Fundraising status: Raised Seed Round (2023)
Clinical Stage: Preclinical
CEO: Colin Foster
Faculty Founder: John Deacon

Fundraising status: Raised Series B (2022)
Clinical Stage: Preclinical
CEO: Chris Duke
Faculty Founder: Peter Glazer


Fundraising status: Currently Raising Series A
Stage: Preclinical
CEO:
Faculty Founder: Demetrios Braddock

Fundraising status: Raised Series A (2023)
Clinical Stage: Preclinical
CEO: Stephen Bloch
Faculty Founders: Sidi Chen


Fundraising status: Raised Seed (2023), Raising Series A
Stage: Commercial
CEO: Markus Helmer
Faculty Founder: Alan Anticevic

Fundraising status: Currently raising Series A
Clinical Stage: Preclinical
CEO: Susan Froshauer
Faculty Founders: Andrew Miranker

Fundraising status: Commercial revenue
Stage: Commercial
CEO: Seeking CEO
Faculty Founder: Lynn Fiellin

Fundraising status: Currently raising Series A
Clinical Stage: Preclinical
CEO: Paul Tessier
Faculty Founders: Elliott Brown

Fundraising status: Raised Seed Round (2022)
Clinical Stage: Preclinical
CEO: Susan Sobolov
Faculty Founders: Anna Pyle & Akiko Iwasaki

Fundraising status: Raised Series B (2022)
Clinical Stage: Phase 1/2
CEO: Sanuj Ravindran
Faculty Founders: Aaron Ring

Fundraising status: Currently raising Series A
Clinical Stage: Preclinical
CEO: Seeking CEO
Faculty Founders: Mark Saltzman & Michael Girardi

Fundraising status: Sponsored research
Stage: Preclinical
CEO: Adi Gottumukkala
Faculty Founder: Jeff Bender

Fundraising status: SBIR (Awarded 2023)
Stage: Preclinical
CEO: Seeking CEO
Faculty Founder: Choukri Ben Mamoun